Flagship explainer
How Kiniksa Pharmaceuticals International, plc makes its money
Start with a dollar of revenue and follow what the filing says remains.
Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.
| Filed line | Value | % of revenue | Source |
|---|---|---|---|
| $678M | 100% |
| |
| Cost of revenue | $77.7M | 11% |
|
| $600M | 89% |
| |
| $77.2M | 11% |
| |
| Income before tax | $88.9M | 13% |
|
| Income tax | $29.9M | 4% |
|
| $59M | 9% |
|
Source:
- SEC filing · FY 2025Filing detailsAccession 0001104659-26-019168